New CEO Mortazavi takes UK biotech e-therapeutics into gene silencing
pharmaphorum
OCTOBER 13, 2020
UK biotech e-therapeutics has a new CEO, with executive chairman and former Silence Therapeutics chief Ali Mortazavi chosen to spearhead the next stage in the company’s development into gene silencing and other areas. The company has considerably more cash than at the start of the year – on 31 July it had £15.1
Let's personalize your content